Octahydro-pyrrolo[3,4-b]pyrrole N-oxides
View Patent ↗The invention relates to octahydro-pyrrolo[3,4-b]pyrrole N-oxides as prodrugs of CNS-active compounds, compositions comprising such compounds, methods for making the compounds, salts, and polymorphs, and methods of treating conditions and disorders using such compounds and compositions. Octahydro-pyrrolo[3,4-b]pyrrole N-oxides of formula (I) are prodrugs of histamine-3 antagonists, and are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Octahydro-pyrrolo[3,4-b]pyrrole N-oxide compounds, methods for using such compounds, compositions for making them, and processes for preparing such compounds are disclosed herein.
1. A compound of the formula:
or a pharmaceutically acceptable salt thereof, wherein:
Z 1 is N or CH.
2. The compound of claim 1 , selected from the group consisting of:
(3aR,5R,6aR)-5-methyl-1-(4′-(6-oxopyridazin-1(6H)-yl)biphenyl-4-yl) octahydropyrrolo[3,4-b]pyrrole 5-oxide;
(3aR,5S,6aR)-5-methyl-1-(4′-(6-oxopyridazin-1(6H)-yl)biphenyl-4-yl) octahydropyrrolo[3,4-b]pyrrole 5-oxide;
(3aR,5R,6aR)-5-methyl-1-(4-(6-(6-oxopyridazin-1(6H)-yl)pyridin-3-yl) phenyl)octahydropyrrolo[3,4-b]pyrrole 5-oxide; and
(3aR,5S,6aR)-5-methyl-1-(4-(6-(6-oxopyridazin-1(6H)-yl)pyridin-3-yl) phenyl)octahydropyrrolo[3,4-b]pyrrole 5-oxide.
3. A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier.
4. A compound that is (3aR,5R,6aR)-5-methyl-1-(4′-(6-oxopyridazin-1(6H)-yl)biphenyl-4-yl)octahydropyrrolo[3,4-b]pyrrole 5-oxide.
5. A compound that is (3aR,5S,6aR)-5-methyl-1-(4′-(6-oxopyridazin-1(6H)-yl)biphenyl-4-yl)octahydropyrrolo[3,4-b]pyrrole 5-oxide.
6. A compound that is (3aR,5R,6aR)-5-methyl-1-(4-(6-(6-oxopyridazin-1(6H)-yl)pyridin-3-yl)phenyl)octahydropyrrolo[3,4-b]pyrrole 5-oxide.
7. A compound that is (3aR,5S,6aR)-5-methyl-1-(4-(6-(6-oxopyridazin-1(6H)-yl)pyridin-3-yl)phenyl)octahydropyrrolo[3,4-b]pyrrole 5-oxide.